This Springer Handbook is a comprehensive, all-in-one reference in medical biotechnology. Covering cutting-edge therapies, regulatory frameworks, and industrial applications, this authoritative volume is essential for professionals and researchers in biotechnology, pharmacology, biomedical engineering, and related fields.
Paediatric acute hepatitis of unknown aetiology (PAHUA) has emerged as a global health concern, yet its cause remains unidentified. This study characterises the clinical and immunological profiles of PAHUA to identify reliable immune biomarkers for accurate diagnosis.
The devastating impact of respiratory infections demonstrates the critical need for novel prophylactic vaccines. In this opinion article, we advocate for bacterial immunotherapies as a complementary tool in our fight against respiratory infections.
Neuroendocrine neoplasms (NENs) comprise a group of rare tumors originating from neuroendocrine cells, which are present in both endocrine glands and scattered throughout the body.
For decades, innate immune cells were considered unsophisticated first responders, lacking the adaptive memory of their T and B cell counterparts. However, mounting evidence demonstrates the surprising complexity of innate immunity.
Trained immunity (TI) represents a memory-like process of innate immune cells. TI can be initiated with various compounds such as fungal b-glucan or the tuberculosis vaccine, Bacillus Calmette-Gue´ rin.
Intravesical administration of Bacillus Calmette-Guérin (BCG) was one of the first FDA-approved immunotherapies and remains a standard treatment for bladder cancer.
We have performed an integral and longitudinal study of the immunological responses triggered by the booster mRNA-1273 vaccination
ntravesical BCG is the gold-standard therapy for non-muscle invasive bladder cancer (NMIBC)
Lung cancer (LC) continues to be the leading cause of cancer-related deaths in both men and women worldwide.
The C-type lectin receptor Dectin-1 was originally described as the β-glucan receptor expressed in myeloid cells, with crucial functions in antifungal responses.
We have analyzed BNT162b2 vaccine-induced immune responses in naive subjects and individuals recovered from coronavirus disease 2019 (COVID-19), both soon after (14 days) and later after (almost 8 months) vaccination.
COVID-19-specific vaccines are efficient prophylactic weapons against SARS-CoV-2 virus.
The Coronavirus Disease of 2019 (COVID-19) pandemic caused by SARS-CoV-2 led the Spanish government to impose a national lockdown in an attempt to control the spread of the infection.
Colorectal cancer (CRC) is the second most deadly and third most commonly diagnosed cancer worldwide.
Conventional type 1 dendritic cells (cDC1s) are central to antitumor immunity and their presence in the tumor microenvironment associates with improved outcomes in patients with cancer.
Vaccines against SARS-CoV-2, the causative agent of the COVID-19 pandemic, are urgently needed.
Myeloid cells are components of the innate immune system that represent the first line of defense.
After both sterile and infectious insults, damage is inflicted on tissues leading to accidental or programmed cell death.
Sensing tissue damage is an ancient function of immune cells that is central to the regulation of inflammation, tissue repair, and immunity.
Myeloid C-type lectin receptors (CLRs) comprise a family of receptors expressed by immune myeloid cells that share homologous C-type lectin domains.
Type-I conventional dendritic cells (cDC1s) are key in inducing adaptive immunity.
β-Glucan-induced trained immunity in myeloid cells leads to long-term protection against secondary infections.
Host injury triggers feedback mechanisms that limit tissue damage.
Myeloid C-type lectin receptors (CLRs) are important sensors of self and non-self that work in concert with other pattern recognition receptors (PRRs).
Dectin-1 embraces Candida glabrata. No abstract available.
In this issue of Immunity, Warnatsch et al. (2017) describe how neutrophils measure their microbial opponents by differential shuttling of reactive oxygen species (ROS)
Candida albicans triggers a differential profile of microRNAs depending on its growing form. No abstract available.
Dectin-1 (Clec7a) is a paradigmatic C-type lectin receptor that binds Syk through a hemITAM motif and couples sensing of pathogens such as fungi to induction of innate responses.